Harrington, Kevin, J., 1958-
Talimogene laherparepvec first-in-class oncolytic immunotherapy / [electronic resource] : Kevin Harrington. - London : Henry Stewart Talks, 2016. - 1 online resource (1 streaming video file (44 min.) : color, sound). - Immunotherapy of cancer, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Immunotherapy of cancer. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Causing tumour cell lysis -- Initiating a specific systemic immune response -- T-VEC as an oncolytic HSV-1 strain -- Assessing cancer immunotherapy through melanoma -- Applicability of oncolytic viral therapy to various cancers.
Access restricted to subscribers.
Mode of access: World Wide Web.
4302 Henry Stewart Talks
Cancer--Immunotherapy.
Drug targeting.
Melanoma--Immunotherapy.
Viruses--Therapeutic use.
Adjuvants, Immunologic--therapeutic use.
Antineoplastic Agents--therapeutic use.
CD8-Positive T-Lymphocytes--immunology.
Granulocyte-Macrophage Colony-Stimulating Factor--immunology.
Herpesvirus 1, Human.
Immunotherapy--methods.
Melanoma--immunology.
Melanoma--therapy.
Neoplasms--immunology.
Neoplasms--therapy.
Oncolytic Virotherapy.
Simplexvirus--genetics.
Talimogene laherparepvec first-in-class oncolytic immunotherapy / [electronic resource] : Kevin Harrington. - London : Henry Stewart Talks, 2016. - 1 online resource (1 streaming video file (44 min.) : color, sound). - Immunotherapy of cancer, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Immunotherapy of cancer. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Causing tumour cell lysis -- Initiating a specific systemic immune response -- T-VEC as an oncolytic HSV-1 strain -- Assessing cancer immunotherapy through melanoma -- Applicability of oncolytic viral therapy to various cancers.
Access restricted to subscribers.
Mode of access: World Wide Web.
4302 Henry Stewart Talks
Cancer--Immunotherapy.
Drug targeting.
Melanoma--Immunotherapy.
Viruses--Therapeutic use.
Adjuvants, Immunologic--therapeutic use.
Antineoplastic Agents--therapeutic use.
CD8-Positive T-Lymphocytes--immunology.
Granulocyte-Macrophage Colony-Stimulating Factor--immunology.
Herpesvirus 1, Human.
Immunotherapy--methods.
Melanoma--immunology.
Melanoma--therapy.
Neoplasms--immunology.
Neoplasms--therapy.
Oncolytic Virotherapy.
Simplexvirus--genetics.